1
|
Ravikumar N, Sreejith G, Law SHC, Anand P, Varghese N, Kagdi S, Kang N, Nashnoush M, Salam S, Ongidi I. Comparative Analysis of Endovascular Intervention and Endarterectomy in Patients with Femoral Artery Disease: A Systematic Review and Meta-Analysis. Hematol Rep 2022; 14:179-202. [PMID: 35735737 PMCID: PMC9222618 DOI: 10.3390/hematolrep14020026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2022] [Revised: 03/25/2022] [Accepted: 05/26/2022] [Indexed: 11/24/2022] Open
Abstract
Peripheral artery disease is a prevalent illness affecting more than 200 million people worldwide. A commonly used technique to manage the condition has been open endarterectomy. However, in recent times, a shift towards minimally invasive techniques has resulted in endovascular intervention as a popular alternative. This review aims to assess the safety and efficacy of endovascular intervention when compared with endarterectomy. A systematic review of the articles published in PubMed, Ovid, Embase, and Scopus within the last 10 years was conducted. The PRISMA guidelines were adhered to, and the Newcastle-Ottawa and NICE quality assessment scales were used. A meta-analysis of proportions was performed using the RStudio software (RStudio Team (2021). RStudio: Integrated Development Environment for R, PBC, Boston, MA, USA). Twenty-six studies were included, with a total of 7126 patients (endovascular, 2496; endarterectomy, 4630). Technical success was greater for endarterectomy than endovascular intervention with an odds ratio of 0.38; 95% CI [0.27–0.54]. In terms of safety as well endovascular intervention was better than endarterectomy with an odds ratio of 0.22; 95% CI [0.15 to 0.31] for wound infection. Endovascular intervention is a safe and effective procedure; however, it cannot be considered superior to endarterectomy.
Collapse
Affiliation(s)
- Nidhruv Ravikumar
- Department of Medicine, School of Medicine, Queen’s University Belfast, Belfast BT7 1NN, UK;
- RadScholars Inc., Halifax, NS B3H 4R2, Canada; (S.H.C.L.); (P.A.); (N.V.); (S.K.); (N.K.); (M.N.); (S.S.); (I.O.)
- Correspondence: ; Tel.: +44-75135-44949
| | - Gopika Sreejith
- Department of Medicine, School of Medicine, Queen’s University Belfast, Belfast BT7 1NN, UK;
- RadScholars Inc., Halifax, NS B3H 4R2, Canada; (S.H.C.L.); (P.A.); (N.V.); (S.K.); (N.K.); (M.N.); (S.S.); (I.O.)
| | - Sharon Hiu Ching Law
- RadScholars Inc., Halifax, NS B3H 4R2, Canada; (S.H.C.L.); (P.A.); (N.V.); (S.K.); (N.K.); (M.N.); (S.S.); (I.O.)
- Department of Radiation Oncology, University of Toronto, Toronto, ON M5S 1A1, Canada
| | - Prakhar Anand
- RadScholars Inc., Halifax, NS B3H 4R2, Canada; (S.H.C.L.); (P.A.); (N.V.); (S.K.); (N.K.); (M.N.); (S.S.); (I.O.)
- Department of Medicine, National University of Ireland, Galway, H91 TK33 Galway, Ireland
| | - Noah Varghese
- RadScholars Inc., Halifax, NS B3H 4R2, Canada; (S.H.C.L.); (P.A.); (N.V.); (S.K.); (N.K.); (M.N.); (S.S.); (I.O.)
- Department of Biochemistry, Western University, London, ON N6A 3K7, Canada
| | - Samrin Kagdi
- RadScholars Inc., Halifax, NS B3H 4R2, Canada; (S.H.C.L.); (P.A.); (N.V.); (S.K.); (N.K.); (M.N.); (S.S.); (I.O.)
- Department of Biological Sciences and Health and Society, University of Toronto, Toronto, ON M5S 1A1, Canada
| | - Navneet Kang
- RadScholars Inc., Halifax, NS B3H 4R2, Canada; (S.H.C.L.); (P.A.); (N.V.); (S.K.); (N.K.); (M.N.); (S.S.); (I.O.)
- Department of Chemistry and Chemical Biology, McMaster University, Hamilton, ON L8S 4L8, Canada
| | - Mohamed Nashnoush
- RadScholars Inc., Halifax, NS B3H 4R2, Canada; (S.H.C.L.); (P.A.); (N.V.); (S.K.); (N.K.); (M.N.); (S.S.); (I.O.)
- School of Health Sciences, Dalhousie University, Halifax, NS B3H 4R2, Canada
- IWK Health Center, Halifax, NS B3K 6R8, Canada
| | - Sihat Salam
- RadScholars Inc., Halifax, NS B3H 4R2, Canada; (S.H.C.L.); (P.A.); (N.V.); (S.K.); (N.K.); (M.N.); (S.S.); (I.O.)
- Department of Biomedical science, York University, Toronto, ON M3J 1P3, Canada
| | - Ibsen Ongidi
- RadScholars Inc., Halifax, NS B3H 4R2, Canada; (S.H.C.L.); (P.A.); (N.V.); (S.K.); (N.K.); (M.N.); (S.S.); (I.O.)
- Department of Human anatomy, School of Medicine, University of Nairobi, Nairobi P.O. Box 30197-00100, Kenya
| |
Collapse
|
2
|
Yamamoto Y, Kawarada O, Ando H, Anzai H, Zen K, Tamura K, Tsukahara K, Tsubakimoto Y, Toma M, Nakamura S, Nakamura H, Hozawa K, Yokoi Y, Yasuda S. Effects of high-speed rotational atherectomy in peripheral artery disease patients with calcified lesions: a retrospective multicenter registry. Cardiovasc Interv Ther 2020; 35:393-397. [PMID: 32112238 DOI: 10.1007/s12928-020-00643-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2019] [Accepted: 01/17/2020] [Indexed: 11/30/2022]
Abstract
Calcified lesions still remain a technical challenge even in the treatment of infrainguinal artery disease. The aim of this retrospective, multicenter observational study was to investigate interventional outcomes of a high-speed rotational atherectomy device (Rotablator™) and to compare clinical outcomes in patients who underwent Rotablator and those who did not even after failed balloon angioplasty because of underlying calcified lesions. This study enrolled patients who underwent Rotablator (Rota group) and those who did not (Non-rota group) between January 2010 and 2014 December at 12 hospitals. A total of 67 limbs and 68 lesions in 65 patients were included (Rota group; 54 limbs and 55 lesions in 52 patients, Non-rota group; 13 limbs and 13 lesions in 13 patients). In the Rota group, a technical success rate was 94.5% with a complication rate of 1.8%, and all lesions underwent subsequent postdilatation following the adjunctive use of Rotablator, and approximately half of above-the-knee lesions underwent stent implantation. The Rota group had a significantly lower clinically driven reintervention rate at 12 months than the Non-rota group (26.5% vs. 58.3%, respectively, p = 0.046). In addition, Rota group showed a trend toward a higher amputation-free survival compared to the Non-rota group at 1 month (Rota; 98.0% vs. Non-rota; 84.6%, respectively, p = 0.10). Rotablator was used as an adjunctive device with a high technical success and a low complication rates, and Patients who underwent Rotablator yielded a significantly lower clinically driven reintervention rate at 12 months compared to those who did not even after failed balloon angioplasty.
Collapse
Affiliation(s)
- Yoshiya Yamamoto
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
| | - Osami Kawarada
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
- Department of Cardiovascular Medicine, Hanwa Memorial Hospital, 7-11-11 Karita, Sumiyoshiku, Osaka, Osaka, 558-0011, Japan.
| | - Hiroshi Ando
- Department of Cardiology, Kasukabe Chuo General Hospital, Kasukabe, Saitama, Japan
| | - Hitoshi Anzai
- Department of Cardiology, Ota Memorial Hospital, Ota, Gunma, Japan
| | - Kan Zen
- Department of Cardiology, Omihachiman Community Medical Center, Omihachiman, Shiga, Japan
| | - Kenji Tamura
- Department of Cardiology, Bell Land General Hospital, Sakai, Osaka, Japan
| | - Kengo Tsukahara
- Department of Cardiology, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan
| | | | - Masanao Toma
- Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan
| | - Shigeru Nakamura
- Department of Cardiology, Kyoto Katsura Hospital, Kyoto, Kyoto, Japan
| | - Hiroaki Nakamura
- Department of Cardiology, Kakogawa East City Hospital, Kakogawa, Hyogo, Japan
| | - Koji Hozawa
- Department of Cardiology, New Tokyo Hospital, Matsudo, Chiba, Japan
| | - Yoshiaki Yokoi
- Department of Cardiology, Kishiwada Tokushukai Hospital, Kishiwada, Osaka, Japan
| | - Satoshi Yasuda
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
| |
Collapse
|
3
|
Combined Use of Excimer Laser and High-Speed Rotational Atherectomy to Overcome a Severely Calcified Lesion in Endovascular Therapy. Case Rep Vasc Med 2019; 2019:1719035. [PMID: 31139490 PMCID: PMC6500656 DOI: 10.1155/2019/1719035] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2019] [Accepted: 04/07/2019] [Indexed: 01/26/2023] Open
Abstract
Although endovascular therapy (EVT) is commonly used in treatment of peripheral artery disease (PAD), severely calcified lesions pose a challenge, in spite of the technical advancement. In this report, we discuss the case of a 74-year-old male with coronary artery disease and end-stage renal disease who presented at our institution with bilateral intermittent claudication. Angiography showed chronic total occlusion (CTO) of the right superficial femoral arteries (SFA). Because the bilateral external iliac arteries demonstrated moderate stenosis, we performed endovascular therapy on the right SFA-CTO using a contralateral approach. With the antegrade wire progressing into the subintimal space, direct distal-SFA puncture was performed and wire externalization was established. However, no devices (minimal balloon, microcatheter, or Crosser system) were able to pass the lesion in antegrade or retrograde manner, even though the child catheter support or needle cracking technique from outside/inside was applied. Therefore, we used a combination of an excimer laser and high-speed rotational atherectomy to overcome the severely calcified lesion. First, the excimer laser catheter (Turbo Elite 0.9 mm) ablated the entry to the CTO; however, it did not pass through completely. Thereafter, the thin microcatheter (Caravel) succeeded in crossing the CTO in an antegrade manner using the BAlloon Deployment using FORcible Manner (BADFORM) technique. After wire-exchange to the Rota-wire, rotational atherectomy (RotaLink Plus 1.5 mm) passed through the CTO. Subsequently, we could dilate the CTO lesion with a conventional balloon followed by bare metal stent deployment. The right ankle-brachial index of the patient improved from being unmeasurable to 0.79, and the intermittent claudication disappeared. This combination therapy, described as the “RASER” technique in coronary section, is accepted for reimbursement. However, these devices in EVT section are considered off-label use in Japan. Therefore, we have to refrain from frequent use of this strategy; however, this method provides an option for severely calcified lesions.
Collapse
|